Aureos Capital

Aureos was established in July 2001 as a joint venture between CDC (UK Commonwealth Development Corporation) and Norfund (Norwegian Investment Fund for Developing Countries) for two purposes: to manage out the Legacy Portfolio of 139 investments in Small and Medium sized businesses originally made by CDC (of which a number of senior Aureos employees had previously managed within CDC consisting of investments in Small and Medium sized businesses in the Emerging Markets) from 1992 onwards, and to promote and manage a new generation of regional emerging market private equity funds, building on the experience gained through the Legacy Portfolio. Aureos Capital was an independent private equity fund manager focused exclusively on the emerging markets. Aureos specialised in providing expansion and buyout capital for low to mid-cap businesses with prospects for strong growth and profitability across Asia Pacific, Africa and Latin America. The firm invests in businesses with proven track records and helps them reach their full potential, by mobilising its management expertise and well-established global network. In February 2012 Dubai-based private equity firm Abraaj bought UK-based Aureos Capital, in a deal that created the world’s largest private equity firm focused on SMEs in the emerging market space. In 2013 the Abraaj Group restructured and the Aureos Capital platform became part of the Abraaj Group.

Type

Private Equity Firm

Headquarters

London, England, UK

Est. cheque size

$136K–$790K

Sectors

Diversified

Regions

Europe, Africa, Australasia

Strategies

Buyout

• London, England, UKHQ
• Bangkok, Thailand
• Colombo, Sri Lanka
• San Jose, Costa Rica
• Sandton, South Africa
• Mumbai, Maharashtra, India